European Commission's recent Calls for tenders

The European Commission's Information Society and Media DG has published:
  • I - a call for tenders for recommendations on exploiting research infrastructure potential in key areas of the information society (e-government, e-health, e-learning);
  • II - a call for tenders for the move towards a European e-infrastructure for e-science digital repositories.

  • I - The aim of the study will be to explore and assess whether and how the needs for e-infrastructure in the government, health and training and education sectors can be met in a coordinated way. The contractor will also investigate possible options to exploit it. The contractor should especially take into account the experience and the lessons learned from the deployment of e-infrastructure in the research sector for deployment in other sectors.
  • II - The contract is to provide a reliable overview of European digital repositories of e-science information, data and knowledge.

    To achieve that, the contractor will interface relevant scientific communities in different Member States and analyse their approach to developing digital repositories of experimental data sets, journals, theses and associated information. An important aspect of the study will be to collect information and analyse the degree of interoperability of the different approaches and technologies. The contractor will also study possible scenarios to build upon common requirements and synergies so that a layer of digital repositories can develop as part of the European research e-infrastructure.

To see the full details of the call, please consult the following web link: Recently published Calls

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...